307 related articles for article (PubMed ID: 205786)
1. Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia.
Avram MM; Feinfeld DA; Huatuco AH
N Engl J Med; 1978 May; 298(18):1000-3. PubMed ID: 205786
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. [Absence of augmentation of the rate of motor nerve conduction following parathyroidectomy in hemodialysed uremic patients (proceedings)].
Drüeke T; Chkoff N; Di Guilio S; Zingraff J; Delons S; Man NK; Jungers P; Crosnier J
J Urol Nephrol (Paris); 1979; 85(4-5):335. PubMed ID: 480448
[No Abstract] [Full Text] [Related]
4. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity.
Goldstein DA; Chui LA; Massry SG
J Clin Invest; 1978 Jul; 62(1):88-93. PubMed ID: 659642
[TBL] [Abstract][Full Text] [Related]
5. Blood levels of middle molecules and their effects on motor nerve conduction velocity.
Botella J; Gea T; Sanz-Guajardo D; Criado M; Torres MT; Guardiola J
Artif Organs; 1981; 4 Suppl():151-5. PubMed ID: 7295082
[TBL] [Abstract][Full Text] [Related]
6. Failure to show a correlation between serum parathyroid hormone, nerve conduction velocity and serum lipids in hemodialysis patients.
Schaefer K; Offermann G; von Herrath D; Schröter R; Stölzel R; Arntz HR
Clin Nephrol; 1980 Aug; 14(2):81-8. PubMed ID: 7408260
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
8. [Uremic neuropathy. Study of the motor conduction rate in patients treated with maintenance hemodialysis and peritoneal dialysis].
Cianchetti C; Carobi C; Perticoni G; Buoncristiani U
Riv Neurol; 1977; 47(1):83-104. PubMed ID: 193173
[TBL] [Abstract][Full Text] [Related]
9. Uremic vagal neuropathy: has parathyroid hormone a pathogenetic role?
Vita G; Savica V; Calabrò R; Padovano I; Manna L; Toscano A; Rotondo S; Bellinghieri G
Funct Neurol; 1986; 1(3):253-9. PubMed ID: 3609857
[TBL] [Abstract][Full Text] [Related]
10. Tibial nerve H-reflex and F-wave studies in patients with uremic neuropathy.
Panayiotopoulos CP; Lagos G
Muscle Nerve; 1980; 3(5):423-6. PubMed ID: 6252459
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone as a uremic neurotoxin.
N Engl J Med; 1978 Aug; 299(7):362-3. PubMed ID: 210381
[No Abstract] [Full Text] [Related]
12. Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients.
Mallamaci F; Zoccali C; Ciccarelli M; Briggs JD
Clin Nephrol; 1986 Apr; 25(4):175-80. PubMed ID: 3516480
[TBL] [Abstract][Full Text] [Related]
13. Reduction by cimetidine of serum parathyroid hormone levels in uremic patients.
Jacob AI; Lanier D; Canterbury J; Bourgoignie JJ
N Engl J Med; 1980 Mar; 302(12):671-4. PubMed ID: 7354765
[No Abstract] [Full Text] [Related]
14. [Velocity of maximal motor nerve conduction in polyneuropathies of uremic patients subjected to various types of hemodialysis for varying periods of time: values and limitations].
Savazzi GM; Arisi L; Bignardi L; Rossi E; Cambi V; Allegri L
Riv Neurol; 1976; 46(1):25-35. PubMed ID: 1013604
[No Abstract] [Full Text] [Related]
15. The effect of high-tone external muscle stimulation on symptoms and electrophysiological parameters of uremic peripheral neuropathy.
Strempska B; Bilinska M; Weyde W; Koszewicz M; Madziarska K; Golebiowski T; Klinger M
Clin Nephrol; 2013 Jan; 79 Suppl 1():S24-7. PubMed ID: 23249529
[TBL] [Abstract][Full Text] [Related]
16. [Motor nerve conduction velocity in uraemic polyneuropathy: correlation with metabolic factors (author's transl)].
Mamoli B; Kopsa H; Maly J; Pateisky K; Gerstenbrand F; Kotzaurek R
Wien Klin Wochenschr; 1976 Dec; 88(23):770-4. PubMed ID: 1014710
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of parathyroid hormone in uremia.
Klahr S; Slatopolsky E
Annu Rev Med; 1986; 37():71-8. PubMed ID: 3010810
[TBL] [Abstract][Full Text] [Related]
18. [Uremic neuropathy and the type of dialysis].
Firenze C; Gallai V; Mattelli L; Mazzotta G; Panzetta AM; Buoncristiani U
Riv Patol Nerv Ment; 1982; 103(6):271-6. PubMed ID: 6326249
[TBL] [Abstract][Full Text] [Related]
19. Severe proximal myopathy in advanced renal failure. Diagnosis and management.
Adeniyi O; Agaba EI; King M; Servilla KS; Massie L; Tzamaloukas AH
Afr J Med Med Sci; 2004 Dec; 33(4):385-8. PubMed ID: 15977450
[TBL] [Abstract][Full Text] [Related]
20. The effect of parathyroid hormone and 1,25 (OH)2D3 on nerve conductance in patients on maintenance hemodialysis.
Ivić MA; Kostić S; Strahinjić S; Stefanović V
Acta Med Iugosl; 1989; 43(5):349-55. PubMed ID: 2626971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
